The association between scleritis and rheumatoid arthritis has been recognized for a long time, one of the earliest reports being that of Holthouse in 1893. The prevalence of scleritis in rheumatoid arthritis is, however, not well established and has been thought to be a rare complication (Smith 1957 , Sevel 1965 , Smiley & Bywaters 1967 , Smiley 1969 .
In 1969 we undertook a survey of scleritis in rheumatoid arthritis to explore the association between these two conditions. We examined 142 consecutive patients with rheumatoid arthritis, most of whom were inpatients at the Royal National Hospital for Rheumatic Diseases in Bath, and all of whom had active, definite or classical rheumatoid arthritis (Ropes et al. 1959) . Five further patients with active rheumatoid arthritis and scleritis were separately included. We also surveyed 142 controls who were patients with degenerative non-inflammatory joint disease and who were matched with the rheumatoid patients for both age and sex. Scleritis was defined according to the criteria of Watson and his coworkers (Watson & Lobascher 1965 , Watson 1966 , Watson et al. 1968 ) and all the cases of active scleritis subsequently developed scleral thinning at the sites of scleral inflammation.
All the rheumatoid patients were carefully assessed from the point of view both of the severity of their disease and of other systemic manifestations (Table 1) . Evidence of scleritis was found in 9 of the 142 patients with rheumatoid arthritis but in none of the controlsa highly significant association.
There was a significant correlation with the presence of rheumatoid nodules. There was a highly significant association with rheumatoid microvasculitis and an association with both pericarditis and pleurisy.
Taking all the systemic complications together as a whole, there is a highly significant correlation with scleritis. These -complications occurred in 11 of the 14 scleritic patients as opposed to 18 of 133 non-scleritic patients. In other words, scleritis complicating rheumatoid arthritis is just one example of active systemic inflammation in rheumatoid arthritis.
One feature we observed was that many of these patients with rheumatoid arthritis and scleritis had few or no symptoms from the scleritis. In several cases the scieritis was discovered only because of our survey and without this specific examination of the sclera it could well have been missed. This is in contrast with scleritis occurring in other diseases, when it usually causes discomfort and can sometimes be extremely painful. There are several possible explanations why scleritis should produce such mild symptoms in rheumatoid arthritis:
(1) All these patients were taking anti-inflammatory analgesic drugs in various amounts. It is possible that these drugs suppress the severity of the scleritis and the symptoms. (2) A second point is the question of the pain threshold of patients with rheumatoid arthritis. Pain threshold can be defined as the severity of any lesion necessary just to produce the symptoms of pain. It might be expected that the rheumatoid patient would have a high pain threshold as he has become used to continuous generalized pain. Huskisson & Hart (1972) , however, looked at rheumatoid patients and found that if anything the pain threshold was lower and rheumatoid patients were more rather than less sensitive to pain. A high pain threshold is unlikely therefore to account for the mildness of the symptoms in rheumatoid scleritis.
(3) A third possibility is that the scleral disease itself in rheumatoid arthritis is different from the scleritis complicating other diseases. The pathology of rheumatoid scleritis is thought to be typical of that of rheumatoid inflammation elsewhere, whereas that complicating at any rate infectious diseases is presumably different.
We have now reviewed the 14 patients with scleritis approximately three years after they were first seen in order to try to relate the natural history of rheumatoid scleritis with the course of the rheumatoid disease itself. Five of these 14 patients had died by the time of the three-year follow up -a mortality rate of 36%. The causes of death in all of these could be related to the rheumatoid arthritis and were as follows. One patient had severe vasculitis and developed an enormous bed sore amongst other ulcers and succumbed to bronchopneumonia. A second patient developed aortic incompetence and eventually died of heart failure and general debility. This is of particular interest in that Pitkeathley et al. (1970) have described an association between scleritis and aortic incompetence in patients without evidence of rheumatoid arthritis. Two further patientswith severe rheumatoid arthritis developed septicxmia and died. Septicwmia is a well-recognized complication of rheumatoid arthritis. The final patient on this list died of several causes but, significantlyimportant were the severe rheumatoid arthritis with vasculitis and ulcers, although she also suffered from diabetes. Therefore, in all these patients the death was directly related to rheumatoid arthritis. This is in contrast with the findings of Reah et al. (1971) , who traced the causes of death in 51 patients with rheumatoid arthritis. They found that in only 12% of these could death be attributed to rheumatoid disease. In a further 38 % it was a possible contributory cause. In their series, therefore, the rheumatoid arthritis was directly related in a maximum of only 50 %. Again, Jacoby et al. (1973) have recently published a follow-up survey of 100 patients with rheumatoid arthritis seen over eleven years. Seventeen died, but in only 5 could death be directly related to the rheumatoid arthritis.
We also examined survival figures in our series of rheumatoid patients who did not have scleritis. Of these 18.5% have died, in contrast to 36% of scleritics. However, although the mortality rate of scleritics appears double that of the non-scleritics, the difference between these two groups is not statistically significant.
All the patients who died were considerably older (mean age 67 years) than those who survived (mean age 51 years). This means that their natural expectancy of life would be shorter than the survivors. However, all those who died had evidence of vasculitis whereas only 4 of the 9 who survived had this complication. Again, rheumatoid nodules were present in 4 of the 5 who died and 5 of the 9 who survived. Evidence of systemic disease was found in all those who died, including arteritis, splenomegaly, pancytopenia, pericarditis, pleurisy, peripheral neuropathy, aortic incompetence and vasculitic ulcers. By contrast, of those who were alive, some did not have extraarticular manifestations of rheumatoid arthritis. We conclude from this that the scleritics who died had more systemic disease than those who survived, but it must also be admitted that they were older and therefore at greater risk.
Surviving Scleritic Patients
We were able to examine' 8 of the 9 surviving scleritic patients. These 8 patients could be clearly divided into two groups:
(1) Six patients had transient episodes of scleritis lasting between three months and one year. This healed leaving scleral thinning and has not recovered since. Of these 6 patients 3 had unilateral scleritis at the onset and 3 had bilateral disease. In 3 the rheumatoid disease had become inactive and correlated well with inactivity of the scleritis.
(2) Two patients persisted with recurrent attacks of scleritis during the three-year period since they were first seen. Both had bilateral disease and there was a positive correlation with the activity of the arthritis. In one of these patients, who also suffered from rheumatoid pleurisy, flare-ups in the eyes occurred with attacks of pleuritic pain.
We have also looked critically at further cases of scleritis to see if they fit into these two patterns. Of 5 further patients seen recently, 3 had transient scleritis lasting only a few months and then completely healed leaving only an area of scleral thinning: 2 were bilateral and one unilateral. The 1 163 other 2 patients had chronic relapsing scleritis, one with recurrent episodes over five years and the other over two years.
All these scleritic patients were receiving powerful antirheumatic drugs. Most were on antiinflammatory analgesics. Some were on steroids, immunosuppressive drugs or penicillamine. The doses of these were varied according to the activity of the rheumatoid disease. In some cases there was convincing improvement on alteration of drug therapy, but in others the effect of these systemic drugs on the scleritis was disappointing.
Summary
We have confirmed a specific association with scleritis and rheumatoid arthritis, the scleritis being associated with the severity of the rheumatoid disease and particularly with the presence of systemic manifestations. When we reviewed these patients three years later, we found that 5 had died and in all of these the cause of death was directly related to the rheumatoid arthritis. We have found scleritis to be a not uncommon complication of rheumatoid arthritis, whereas others feel it is rare. The answer may be that there are two patterns or two extremes of a spectrum of scleritis in rheumatoid arthritis. The most common type is mild transient inflammation which often produces few or no symptoms and is easily missed unless specifically looked for, and heals leaving only mild scleral thinning; it often does not present either to the rheumatologist or to the ophthalmic surgeon. The chronic relapsing form continues to recur for many years and can lead to severe scleral atrophy. This is less common but it is this type alone which is usually reported. In the last 25 years at Taplow examination of the eyes of 668 patients with Still's disease has revealed 76 children with iridocyclitis and these have been the subject of a detailed study (Schaller et al. 1972) . This is the basic lesion from which all the main ocular problems stem with the exception of keratoconjunctivitis sicca which has been found at all ages from 4 upwards.
Two striking observations emerge in these patients with iridocyclitis: (1) None has typical systemic disease, as shown by recurrent fevers, rheumatoid rash or other extra-articular manifestations such as rheumatoid nodules. (2) None has rheumatoid factor positive disease.
As has been shown in the past (Smiley 1965 ) there are two contrasting types of iridocyclitis associated with Still's diseaseacute and chronic.
Of our 76 patients 15 are of the acute type, all male, the arthritis developing on average at 9.3 years of agemuch later than in the larger group with chronic iridocyclitis. The mean age of ocular involvement was 16.9 years and recurrent attacks in one or other eye occurred in 9 patients. There is nothing distinctive about the eye in an acute attack and it resolves almost completely if adequately treated with atropine and cortisone in the early stages. All the patients in this group have so far retained normal vision except one whose early treament was neglected elsewhere. The significant features of this group are the initial polyarthritis and the later changes in the sacroiliac joints and spine which clinically and radiographically are typical of ankylosing spondylitis. It appears, therefore, that acute iridocyclitis in a child who seems to have chronic polyarthritis is an indication that he will probably develop spondylitis and that the visual prognosis is good with adequate local treatment.
Of the 61 patients with chronic iridocyclitis 47 are girls and 14 boys with a mean age onset of arthritis of 3.9 years -very different from the acute group and from the average 8-year-old onset in the control group of 592 who did not develop iridocyclitis. In 6 of these children eye involvement preceded joint involvement by periods ranging from two months to as much as eleven years and the importance of following up a case of iritis in a child over many years is obvious if the cause is to be established. Because of the lack of symptoms with this chronic type of iridocyclitis the precise time of onset can be difficult to deter-
